ArticleClinical and public health guidelines2026
GIN-McMaster Guideline Development Checklist Extension for Integrating Artificial Intelligence in the Health Guideline Enterprise.
Article in Clinical and public health guidelines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Artificial intelligence (AI) may support several processes of the health guideline enterprise. This article describes the development of an extension of the Guidelines International Journal (GIN)-McMaster Guideline Development Checklist (GDC) for integrating AI in the guideline enterprise. This development has been led by the GIN-AI Working Group. Methods: We started by prompting a large language model (LLM) for items related to the use of AI in each of the steps of the original GDC. Subsequently, the members of the working group engaged in a set of iterative discussions, resulting in item refinement and in a consensus first version of the extension. We retrospectively applied this first version to a case use of guidelines incorporating AI in their development (Allergic Rhinitis and its Impact on Asthma [ARIA] 2024-2025 guidelines), leading to further refinement and to the approval of the final extension tool. Results: Prompting LLMs resulted in the generation of 149 items. Of those, 117 were removed and 19 were modified by members of the working group. On the other hand, 17 new items were added during the iterative discussion process. The retrospective application of the extension led to changes in the wording of four items. The final version of the checklist extension has been approved with 49 items modifying or adding to the original GDC. Discussion: We have developed an extension of the GIN-McMaster GDC that encompasses a set of conduct standards that are intended to facilitate the comprehensive and transparent integration of AI in the health guideline enterprise. Clinical Trial Registration: Not applicable. This study is not a clinical trial.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.